Inovio Pharmaceuticals Inc vs Tripadvisor Inc Common Stock — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Tripadvisor Inc Common Stock trades at $13.82 (market cap $1.68B). The key difference: Tripadvisor Inc Common Stock is far larger — about 18.8× Inovio Pharmaceuticals Inc's market cap, and Tripadvisor Inc Common Stock is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | TRIP | |
|---|---|---|
Market Cap | $89.27M | $1.68B |
Sector | Health | Consumer Cyclical |
52-Week High | $2.87 | $19.14 |
52-Week Low | $1.05 | $9.24 |
Enterprise Value | $60.28M | $1.80B |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →